Intas Pharmaceuticals Ltd — Pioglitazone Exporter Profile
Indian Pharmaceutical Exporter · #13 for Pioglitazone · $385.6K export value · DGFT Verified
Intas Pharmaceuticals Ltd is the #13 Indian exporter of Pioglitazone with $385.6K in export value and 29 verified shipments. Intas Pharmaceuticals Ltd holds a 1.0% market share in Pioglitazone exports across 7 countries.
Intas Pharmaceuticals Ltd — Pioglitazone Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Ltd Export Pioglitazone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ITALY | $903.5K | 56 | 28.1% |
| CROATIA | $790.7K | 40 | 24.6% |
| POLAND | $640.1K | 86 | 19.9% |
| UNITED KINGDOM | $453.1K | 97 | 14.1% |
| UNITED STATES | $207.7K | 7 | 6.5% |
| NETHERLANDS | $90.5K | 68 | 2.8% |
| AUSTRIA | $77.1K | 23 | 2.4% |
| CANADA | $32.4K | 6 | 1.0% |
| SPAIN | $12.2K | 1 | 0.4% |
| GREECE | $2.6K | 4 | 0.1% |
Intas Pharmaceuticals Ltd exports Pioglitazone to 11 countries. The largest destination is ITALY accounting for 28.1% of Intas Pharmaceuticals Ltd's Pioglitazone shipments, followed by CROATIA (24.6%) and POLAND (19.9%). These destinations reflect Intas Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pioglitazone from Intas Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | ITALY | $482.9K | 30 |
| ACCORD UK | UNITED KINGDOM | $452.6K | 61 |
| NOVATIN LIMITED | CROATIA | $288.0K | 9 |
| S.C.F. SRL | ITALY | $265.0K | 11 |
| S C F SRL | ITALY | $240.4K | 9 |
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $207.7K | 7 |
| BIOTON S.A. | POLAND | $205.5K | 24 |
| BIOTON S A | POLAND | $130.2K | 6 |
| NOVATIN LTD CONSIGNEMENT STOCK | CROATIA | $128.0K | 10 |
| NOVATIN LTD | CROATIA | $115.2K | 3 |
Intas Pharmaceuticals Ltd supplies Pioglitazone to 36 buyers globally. The largest buyer is TO THE ORDER (ITALY), followed by ACCORD UK (UNITED KINGDOM) and NOVATIN LIMITED (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pioglitazone Export Value and How Much Does Intas Pharmaceuticals Ltd Contribute?
India exported $35.2M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. Intas Pharmaceuticals Ltd contributes $385.6K to this total, accounting for 1.0% of India's Pioglitazone exports. Intas Pharmaceuticals Ltd ships Pioglitazone to 11 countries through 36 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Ltd's Pioglitazone Exports?
Intas Pharmaceuticals Ltd's average Pioglitazone shipment value is $13.3K per consignment, based on 29 shipments totaling $385.6K. The largest destination is ITALY (28.1% of Intas Pharmaceuticals Ltd's Pioglitazone exports).
How Does Intas Pharmaceuticals Ltd Compare to Other Indian Pioglitazone Exporters?
Intas Pharmaceuticals Ltd ranks #13 among 115 Indian Pioglitazone exporters with a 1.0% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($15.2M), AUROBINDO PHARMA LIMITED ($4.0M), INTAS PHARMACEUTICALS LIMITED ($3.4M). Intas Pharmaceuticals Ltd processed 29 shipments to 7 destination countries.
What Pioglitazone Formulations Does Intas Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PH.DRU.& MED.: NOVAPIO PIOGLITAZONE 30MGTABLETS EACH TABLET CONTAINS: PIOGLITAZONE HCL 30MG [2X15T PER PACK] BATCH NO | $288.0K | 9 |
| PHARMA DRUGS & MEDI PIOGLITAZONE TABLETS | $200.8K | 6 |
| PHARMACEUTICAL DRUGS & MEDICINE.PIOGLITAZONE 30MG 2X14T (DOC ITALY EACH UNCOATEDTABLET CONTS.PIOGLITAZONE HYDROCHLORIDE | $136.6K | 5 |
| PH. DRU & MEDI PIOGLITAZONE 30MG 2X14T(EACH UNCOATED TAB. CONTAINS PIOGLITAZONE HYDROCHLORIDE EQ.TOPIOGLITAZONE 30MGTBS | $101.0K | 12 |
| PHARM.DRUGS&MEDI.PIOGLITAZONE 15MG 2X14T | $100.2K | 3 |
| PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETS | $97.2K | 18 |
| PHARMA DRUGS & MEDI PIOGLITAZONE 45MG 2X14T(ACCORD-UK AS PER INVOICE | $90.9K | 5 |
| PH.DRU.& MED.PIOGLITAZONE 15MG 2X14T(DOC ITALY EACH UNC. TAB CONTA. PIOGLITAZONE HYDROCHLORIDE EQ. TO PIOGLITAZONE 15 MG | $89.9K | 3 |
| PH.DRU.& MED.: PIOGLITAZONE 30MG TABLETS | $89.4K | 18 |
| PHARMA DRUGS & MEDI PIOGLITAZONE 45MG 2X | $86.1K | 13 |
Intas Pharmaceuticals Ltd exports 178 distinct Pioglitazone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PH.DRU.& MED.: NOVAPIO PIOGLITAZONE 30MGTABLETS EACH TABLET with 9 shipments worth $288.0K.
How Does Intas Pharmaceuticals Ltd Compare to Nearest Pioglitazone Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MEDLEY PHARMACEUTICALS LIMITED | $616.1K | 78 | 2 | $7.9K |
| 12 | TORRENT PHARMACEUTICALS LTD | $493.8K | 18 | 3 | $27.4K |
| 13 | INTAS PHARMACEUTICALS LTD ★ | $385.6K | 29 | 7 | $13.3K |
| 14 | MYLAN LABORATORIES LIMITED | $295.0K | 32 | 1 | $9.2K |
| 15 | CIPLA LIMITED | $281.3K | 18 | 1 | $15.6K |
Intas Pharmaceuticals Ltd ranks #13 among 115 Indian Pioglitazone exporters. Average shipment value of $13.3K compared to the market average of $305.7K. The closest competitors by value are MEDLEY PHARMACEUTICALS LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Pioglitazone Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR | 249 | 9.3% |
| HYDERABAD ICD | 229 | 8.6% |
| DELHI AIR CARGO ACC (INDEL4) | 206 | 7.7% |
| SAHAR AIR | 205 | 7.7% |
| HYDERABAD ICD (INSNF6) | 203 | 7.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 143 | 5.3% |
| MUNDRA SEA | 127 | 4.7% |
| CMA CGM LOGISTICS PARK ICD | 126 | 4.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pioglitazone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 502 individual customs records matching Intas Pharmaceuticals Ltd exporting Pioglitazone, covering 178 formulations to 11 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pioglitazone Export Data from Intas Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Ltd's Pioglitazone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Pioglitazone Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current shipment-level data, contact TransData Nexus.